Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 798743, 7 pages
http://dx.doi.org/10.1155/2013/798743
Research Article

Predicting the DPP-IV Inhibitory Activity Based on Their Physicochemical Properties

1School of Materials Science and Engineering, Shanghai University, 149 Yan-Chang Road, Shanghai 200072, China
2Department of Chemistry, College of Sciences, Shanghai University, 99 Shang-Da Road, Shanghai 200444, China
3Department of Neurosurgery, Changhai Hospital, Second Military Medical University, 168 Chang-Hai Road, Shanghai 200433, China

Received 29 March 2013; Revised 10 May 2013; Accepted 28 May 2013

Academic Editor: Yudong Cai

Copyright © 2013 Tianhong Gu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. H. Kim and M. K. Lee, “The incretins and pancreatic beta-cells: use of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide to cure type 2 diabetes mellitus,” Korean Diabetes Journal, vol. 34, no. 1, pp. 2–9, 2010. View at Publisher · View at Google Scholar
  2. A. Sarashina, S. Sesoko, M. Nakashima et al., “Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male japanese subjects,” Clinical Therapeutics, vol. 32, no. 6, pp. 1188–1204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Augustyns, P. Van der Veken, and A. Haemers, “Inhibitors of proline-specific dipeptidyl peptidases: DPP IV inhibitors as a novel approach for the treatment of type 2 diabetes,” Expert Opinion on Therapeutic Patents, vol. 15, no. 10, pp. 1387–1407, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. A. E. Weber, “Dipeptidyl peptidase IV inhibitors for the treatment of diabetes,” Journal of Medicinal Chemistry, vol. 47, no. 17, pp. 4135–4141, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. S. D. Edmondson, A. Mastracchio, R. J. Mathvink et al., “(2S,3S)-3-amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-[1, 2,4]triazolo[1,5-a]-pyridin-6-ylphenyl)butanamide: a selective α-amino amide dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes,” Journal of Medicinal Chemistry, vol. 49, no. 12, pp. 3614–3627, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. L. Duffy, B. A. Kirk, L. Wang et al., “4-Aminophenylalanine and 4-aminocyclohexylalanine derivatives as potent, selective, and orally bioavailable inhibitors of dipeptidyl peptidase IV,” Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 10, pp. 2879–2885, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Xu, L. Wei, R. J. Mathvink et al., “Discovery of potent, selective, and orally bioavailable oxadiazole-based dipeptidyl peptidase IV inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 20, pp. 5373–5377, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Xu, L. Wei, R. Mathvink et al., “Discovery of potent, selective, and orally bioavailable pyridone-based dipeptidyl peptidase-4 inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 5, pp. 1346–1349, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. T. S. Garcia and K. M. Honório, “Two-dimensional quantitative structure-activity relationship studies on bioactive ligands of peroxisome proliferator-activated receptor δ,” Journal of the Brazilian Chemical Society, vol. 22, no. 1, pp. 65–72, 2011. View at Google Scholar · View at Scopus
  10. G. C. García, I. Luque Ruiz, and M. Á. Gómez-Nieto, “Analysis and study of molecule data sets using snowflake diagrams of weighted maximum common subgraph trees,” Journal of Chemical Information and Modeling, vol. 51, no. 6, pp. 1216–1232, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Jana, A. K. Halder, N. Adhikari, M. K. Maiti, C. Mondal, and T. Jha, “Chemometric modeling and pharmacophore mapping in coronary heart disease: 2-arylbenzoxazoles as cholesteryl ester transfer protein inhibitors,” MedChemComm, vol. 2, no. 9, pp. 840–852, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Kovalishyn, V. Tanchuk, L. Charochkina, I. Semenuta, and V. Prokopenko, “Predictive QSAR modeling of phosphodiesterase 4 inhibitors,” Journal of Molecular Graphics and Modelling, vol. 32, pp. 32–38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Niu, Q. Su, X. C. Yuan, W. Lu, and J. Ding, “QSAR study on 5-lipoxygenase inhibitors based on support vector machine,” Medicinal Chemistry, vol. 8, no. 6, pp. 1108–1116, 2012. View at Google Scholar
  14. S. Paliwal, D. Seth, D. Yadav, R. Yadav, and S. Paliwal, “Development of a robust QSAR model to predict the affinity of pyrrolidine analogs for dipeptidyl peptidase IV (DPP-IV),” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 26, no. 1, pp. 129–140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Murugesan, N. Sethi, Y. S. Prabhakar, and S. B. Katti, “CoMFA and CoMSIA of diverse pyrrolidine analogues as dipeptidyl peptidase IV inhibitors: active site requirements,” Molecular Diversity, vol. 15, no. 2, pp. 457–466, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. D. Gao, D. Feng, R. P. Sheridan et al., “Modeling assisted rational design of novel, potent, and selective pyrrolopyrimidine DPP-4 inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 14, pp. 3877–3879, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Y. Yang, M. J. Li, Q. Su, M. Wu, T. Gu, and W. Lu, “QSAR studies on pyrrolidine amides derivatives as DPP-IV inhibitors for type 2 diabetes,” Medicinal Chemistry Research, 2013. View at Publisher · View at Google Scholar
  18. S. Peng, Z. Jian-Wei, Z. Peng, and X. Lin, “QSPR modeling of bioconcentration factor of nonionic compounds using Gaussian processes and theoretical descriptors derived from electrostatic potentials on molecular surface,” Chemosphere, vol. 83, no. 8, pp. 1045–1052, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Gu, W. Lu, X. Bao, and N. Chen, “Using support vector regression for the prediction of the band gap and melting point of binary and ternary compound semiconductors,” Solid State Sciences, vol. 8, no. 2, pp. 129–136, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Zhu, W. Lu, L. Liu, T. Gu, and B. Niu, “Classification of Src kinase inhibitors based on support vector machine,” QSAR and Combinatorial Science, vol. 28, no. 6-7, pp. 719–727, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Kovalishyn, J. Aires-de-Sousa, C. Ventura, R. Elvas Leitão, and F. Martins, “QSAR modeling of antitubercular activity of diverse organic compounds,” Chemometrics and Intelligent Laboratory Systems, vol. 107, no. 1, pp. 69–74, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Xing, R. Goulet, and K. Johnson, “Statistical analysis and compound selection of combinatorial libraries for soluble epoxide hydrolase,” Journal of Chemical Information and Modeling, vol. 51, no. 7, pp. 1582–1592, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Kar, O. Deeb, and K. Roy, “Development of classification and regression based QSAR models to predict rodent carcinogenic potency using oral slope factor,” Ecotoxicology and Environmental Safety, vol. 82, pp. 85–95, 2012. View at Publisher · View at Google Scholar
  24. B. Niu, X. C. Yuan, P. Roeper et al., “HIV-1 protease cleavage site prediction based on two-stage feature selection method,” Protein and Peptide Letters, vol. 20, no. 3, pp. 290–298, 2013. View at Google Scholar
  25. B. Niu, Y. D. Cai, W. C. Lu, G. Z. Li, and K. C. Chou, “Predicting protein structural class with AdaBoost Learner,” Protein and Peptide Letters, vol. 13, no. 5, pp. 489–492, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Niu, Y. H. Jin, K. Y. Feng et al., “Predicting membrane protein types with bagging learner,” Protein and Peptide Letters, vol. 15, no. 6, pp. 590–594, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Niu, Y. H. Jin, K. Y. Feng, W. C. Lu, Y. D. Cai, and G. Z. Li, “Using AdaBoost for the prediction of subcellular location of prokaryotic and eukaryotic proteins,” Molecular Diversity, vol. 12, no. 1, pp. 41–45, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Niu, Y. Jin, L. Lu et al., “Prediction of interaction between small molecule and enzyme using AdaBoost,” Molecular Diversity, vol. 13, no. 3, pp. 313–320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Niu, Y. Jin, W. Lu, and G. Li, “Predicting toxic action mechanisms of phenols using AdaBoost Learner,” Chemometrics and Intelligent Laboratory Systems, vol. 96, no. 1, pp. 43–48, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Niu, L. Lu, L. Liu et al., “HIV-1 protease cleavage site prediction based on amino acid property,” Journal of Computational Chemistry, vol. 30, no. 1, pp. 33–39, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. Q. Su, W. C. Lu, B. Niu, X. Liu, and T. H. Gu, “Classification of the toxicity of some organic compounds to tadpoles (Rana Temporaria) through integrating multiple classifiers,” Molecular Informatics, vol. 30, no. 8, pp. 672–675, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. I. L. Lu, S. J. Lee, H. Tsu et al., “Glutamic acid analogues as potent dipeptidyl peptidase IV and 8 inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 15, no. 13, pp. 3271–3275, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Y. Tsai, T. Hsu, C. T. Chen et al., “Rational design and synthesis of potent and long-lasting glutamic acid-based dipeptidyl peptidase IV inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 19, no. 7, pp. 1908–1912, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Weber, “JChem base—chemAxon,” Chemistry World, vol. 5, no. 10, pp. 65–66, 2008. View at Google Scholar
  35. 2013, http://www.chemaxon.com/.
  36. S. S. Yang, W. C. Lu, T. H. Gu, L. M. Yan, and G. Z. Li, “QSPR study of n-octanol/water partition coefficient of some aromatic compounds using support vector regression,” QSAR and Combinatorial Science, vol. 28, no. 2, pp. 175–182, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Todeschini, “Dragon 5.0: software for molecular descriptors,” in Milano Chemometrics and QSAR Research Group, University of Milano-Bicocca, Milan, Italy, 2004. View at Google Scholar
  38. V. Mukherjee, K. Singh, N. P. Singh, and R. A. Yadav, “Quantum chemical determination of molecular geometries and interpretation of FTIR and Raman spectra for 2,4,5- and 3,4,5-tri-fluoro-benzonitriles,” Spectrochimica Acta A, vol. 71, no. 4, pp. 1571–1580, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Chen, Z. Yi, S. J. Chen, J. S. Luo, Y. G. Yi, and Y. J. Tang, “Study of density functional theory for surface-enhanced raman spectra of p-aminothiophenol,” Spectroscopy and Spectral Analysis, vol. 31, no. 11, pp. 2952–2955, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Zhang, “A leave-one-out cross validation bound for kernel methods with applications in learning,” Computational Learning Theory Proceedings, vol. 2111, pp. 427–443, 2001. View at Google Scholar
  41. J. Yuan, Y. M. Li, C. L. Liu, and X. F. Zha, “Leave-one-out cross-validation based model selection for manifold regularization,” in Advances in Neural Networks, vol. 6063 of Lecture Notes in Computer Science, pp. 457–464, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Kompany-Zareh, “An improved QSPR study of the toxicity of aliphatic carboxylic acids using genetic algorithm,” Medicinal Chemistry Research, vol. 18, no. 2, pp. 143–157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Goodarzi, B. Dejaegher, and Y. Vander Heyden, “Feature selection methods in QSAR studies,” Journal of Aoac International, vol. 95, no. 3, pp. 636–651, 2012. View at Google Scholar
  44. C. Ding and H. Peng, “Minimum redundancy feature selection from microarray gene expression data,” in Proceedings of the IEEE Bioinformatics Conference, pp. 185–205, August 2003. View at Publisher · View at Google Scholar
  45. Z. He, J. Zhang, X. H. Shi et al., “Predicting drug-target interaction networks based on functional groups and biological features,” PLoS ONE, vol. 5, no. 3, Article ID e9603, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. B. Üstün, W. J. Melssen, and L. M. C. Buydens, “Facilitating the application of Support Vector Regression by using a universal Pearson VII function based kernel,” Chemometrics and Intelligent Laboratory Systems, vol. 81, no. 1, pp. 29–40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. E. Frank, M. Hall, L. Trigg, G. Holmes, and I. H. Witten, “Data mining in bioinformatics using Weka,” Bioinformatics, vol. 20, no. 15, pp. 2479–2481, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Chen, L. Lu, K. Feng et al., “Multiple classifier integration for the prediction of protein structural classes,” Journal of Computational Chemistry, vol. 30, no. 14, pp. 2248–2254, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. 2013, http://www.chemaxon.com/products/calculator-plugins/.